Valuation: Bristol-Myers Squibb Company

Market Cap 118B 103B 94.87B 87.62B 166B 11,214B 169B 1,133B 445B 5,525B 441B 432B 18,992B P/E 2026 *
11.3x
P/E 2027 * 11.2x
Enterprise Value 147B 128B 118B 109B 207B 13,993B 211B 1,414B 555B 6,894B 551B 539B 23,699B EV / Sales 2026 *
3.1x
EV / Sales 2027 * 3.03x
Free-Float
69.8%
Yield 2026 *
4.37%
Yield 2027 * 4.45%
1 day-0.62%
1 week-0.95%
Current month-0.07%
1 month+1.20%
3 months-1.77%
6 months+3.08%
Current year+6.75%
1 week 56.49
Extreme 56.49
58.49
1 month 53.44
Extreme 53.44
58.88
Current year 52.06
Extreme 52.06
62.89
1 year 42.52
Extreme 42.52
62.89
3 years 39.35
Extreme 39.35
65.38
5 years 39.35
Extreme 39.35
81.44
10 years 39.35
Extreme 39.35
81.44
Manager TitleAgeSince
Chief Executive Officer 55 2023-10-31
Director of Finance/CFO 58 2019-11-19
Chief Tech/Sci/R&D Officer 53 2021-12-31
Director TitleAgeSince
Chairman 55 2024-03-31
Director/Board Member 61 2016-03-31
Director/Board Member 71 2017-02-20
Date Insider Type Main position Quantity % Market Cap.
Jun. 29Free

Director

607 0.0000%
Jun. 29Free

Director

607 0.0000%
Jun. 29Free

Director

889 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-0.62%-0.95%+22.88%-8.30% 118B
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -1.12%-3.02%+26.34%+50.20% 369.15B
Weighted average by Cap. -1.29%-2.89%+36.31%+80.97%

Financials

2026 *2027 *
Net sales 47.34B 41.41B 38.2B 35.28B 66.94B 4,515B 68.06B 456B 179B 2,224B 178B 174B 7,647B 46.31B 40.51B 37.36B 34.51B 65.48B 4,417B 66.58B 446B 175B 2,176B 174B 170B 7,480B
Net income 10.53B 9.21B 8.5B 7.85B 14.89B 1,004B 15.14B 102B 39.86B 495B 39.54B 38.68B 1,701B 10.26B 8.97B 8.28B 7.64B 14.5B 978B 14.75B 98.88B 38.83B 482B 38.51B 37.68B 1,657B
Net Debt 29.14B 25.49B 23.51B 21.71B 41.2B 2,779B 41.89B 281B 110B 1,369B 109B 107B 4,706B 22.71B 19.86B 18.32B 16.92B 32.11B 2,166B 32.65B 219B 85.97B 1,067B 85.26B 83.41B 3,668B
Logo Bristol-Myers Squibb Company
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques. The United States account for 69.1% of net sales.
Employees
32,500
Date Price Change Volume
26-07-10 $57.58 -0.62% 11,203,566
26-07-09 $57.94 +0.70% 7,628,832
26-07-08 $57.54 -0.74% 8,004,476
26-07-07 $57.97 +2.24% 10,048,425
26-07-06 $56.70 -2.46% 9,313,029
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
57.58USD
Average target price
62.96USD
Spread / Average Target
+9.34%

Quarterly revenue - Rate of surprise